# Supernus Pharmaceuticals Inc. (SUPN) — Gross Profit

## Annual Gross Profit (USD)

| Year | Gross Profit |
| --- | --- |
| 2025 | $644M |
| 2024 | $584M |
| 2023 | $524M |
| 2022 | $580M |
| 2020 | $468M |
| 2019 | $376M |
| 2018 | $394M |
| 2017 | $287M |
| 2016 | $203M |
| 2015 | $139M |
| 2014 | $87M |
| 2013 | $11M |

## Quarterly Gross Profit (USD)

| Quarter | Gross Profit |
| --- | --- |
| 2026-03-31 | $184M |
| 2025-09-30 | $173M |
| 2025-06-30 | $149M |
| 2025-03-31 | $134M |
| 2024-09-30 | $158M |
| 2024-06-30 | $150M |
| 2024-03-31 | $127M |
| 2023-09-30 | $134M |
| 2023-06-30 | $114M |
| 2023-03-31 | $130M |
| 2022-09-30 | $151M |
| 2022-06-30 | $150M |
| 2022-03-31 | $135M |
| 2021-09-30 | $130M |
| 2021-06-30 | $116M |
| 2021-03-31 | $116M |
| 2020-09-30 | $134M |
| 2020-06-30 | $118M |
| 2020-03-31 | $91M |
| 2019-09-30 | $97M |
| 2019-06-30 | $101M |
| 2019-03-31 | $82M |
| 2018-09-30 | $99M |
| 2018-06-30 | $96M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/SUPN/gross-profit)
